New treatment can zap cancer cells and avoid healthy tissue

Australian researchers say they have developed a cancer treatment which can identify and kill individual cancer cells.

The treatment which uses antibodies and DNA to target the cells, is attached to a radioactive atom, which destroys the cancer cells.

Apparently the cancer-killing molecules have already been effective in laboratory tests and could undergo clinical trials within five years.

Dr Tom Karagiannis, of the Peter MacCallum Cancer Centre, Melbourne says the treatment is a first as it uses two levels of targeting.

Karagiannis says with the treatment they target not only the cancer cell, but also the DNA of the cell, and he says this is the first time this has been done using these types of isotopes.

Dr Karagiannis says the new treatment is the most specific yet developed, and the radiation technique is aimed at only killing cancer cells.

It apparently irradiates a volume of only one millionth of a millimetre and because it does that, they are able to kill cancer cells specifically without doing damage to healthy tissue.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
IFITM3 found to be critical regulator of immunotherapy sensitivity in small cell lung cancer